TCG Crossover Management

TCG Crossover Management as of Dec. 31, 2023

Portfolio Holdings for TCG Crossover Management

TCG Crossover Management holds 29 positions in its portfolio as reported in the December 2023 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Structure Therapeutics Adrs (GPCR) 9.5 $86M 2.1M 40.76
Inhibrx Comm 7.4 $67M 1.8M 38.00
Icosavax Comm 6.5 $58M 3.7M 15.76
AN2 Therapeutics Comm (ANTX) 6.1 $55M 2.7M 20.49
Rayzebio Comm 6.0 $54M 870k 62.17
Aerovate Therapeutics Comm (AVTE) 5.5 $50M 2.2M 22.63
Geron Corp Comm (GERN) 5.5 $49M 23M 2.11
Savara Comm (SVRA) 5.2 $47M 10M 4.70
Gracell Biotechnologies Adrs 5.0 $45M 4.5M 10.04
Madrigal Pharmaceuticals Comm (MDGL) 4.6 $42M 180k 231.38
Kalvista Pharmaceuticals Comm (KALV) 4.6 $42M 3.4M 12.25
Silence Therapeutics Adrs (SLN) 4.1 $37M 2.1M 17.37
Compass Pathways Adrs (CMPS) 3.7 $34M 3.9M 8.75
Cogent Biosciences Comm (COGT) 3.7 $33M 5.6M 5.88
Tyra Biosciences Comm (TYRA) 3.1 $28M 2.0M 13.85
Tourmaline Bio Comm (TRML) 2.9 $26M 1.0M 26.18
Tarsus Pharmaceuticals Comm (TARS) 2.6 $23M 1.1M 20.25
Dyne Therapeutics Comm (DYN) 2.4 $22M 1.7M 13.30
Kura Oncology Comm (KURA) 2.3 $21M 1.4M 14.38
Centessa Pharmaceuticals Comm (CNTA) 1.8 $16M 2.0M 7.96
Vistagen Therapeutics Comm 1.5 $14M 2.7M 5.14
Abivax SA Comm (ABVX) 1.3 $12M 1.1M 10.70
Cabaletta Bio Comm (CABA) 1.2 $11M 487k 22.70
Entrada Therapeutics Comm (TRDA) 1.0 $8.8M 585k 15.09
Nurix Therapeutics Comm (NRIX) 0.8 $7.4M 718k 10.32
C4 Therapeutics Comm (CCCC) 0.8 $7.2M 1.3M 5.65
Taysha Gene Therapies Comm (TSHA) 0.6 $5.2M 2.9M 1.77
Ventyx Biosciences Comm (VTYX) 0.2 $2.0M 816k 2.47
Kodiak Sciences Comm (KOD) 0.1 $815k 268k 3.04